Ingalls & Snyder LLC Becton Dickinson & CO Transaction History
Ingalls & Snyder LLC
- $2.55 Billion
- Q4 2024
A detailed history of Ingalls & Snyder LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Ingalls & Snyder LLC holds 2,229 shares of BDX stock, worth $499,652. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,229
Previous 2,229
-0.0%
Holding current value
$499,652
Previous $537,000
5.77%
% of portfolio
0.02%
Previous 0.02%
Shares
21 transactions
Others Institutions Holding BDX
# of Institutions
1,803Shares Held
260MCall Options Held
1.27MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA26.7MShares$5.99 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$4.99 Billion0.12% of portfolio
-
State Street Corp Boston, MA14.1MShares$3.16 Billion0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$2.77 Billion0.32% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.1MShares$2.72 Billion1.7% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $63.9B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...